JIP
ADMA icon

Jaffetilchin Investment Partners’s ADMA Biologics ADMA Stock Holding History

Jaffetilchin Investment Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-575
Closed -$11.5K – 393
2024
Q3 		$11.5K Buy
+575
New +$8.94K ﹤0.01% 873
2021
Q4 		– Sell
-14,250
Closed -$16K – 346
2021
Q3 		$16K Hold
14,250
– – ﹤0.01% 361
2021
Q2 		$23K Hold
14,250
– – ﹤0.01% 368
2021
Q1 		$25K Hold
14,250
– – ﹤0.01% 362
2020
Q4 		$28K Buy
+14,250
New +$30K ﹤0.01% 272

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jaffetilchin Investment Partners's ADMA Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of ADMA Biologics (ADMA) in Q4 2024, closing a stake of 575 shares — an estimated $11.5K sold.

Jaffetilchin Investment Partners first reported a position in ADMA in Q4 2020 and held it in 5 quarters. The position peaked at $28K in Q4 2020. 321 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining ADMA Biologics position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 575 ADMA Biologics shares in Q4 2024, an estimated $11.5K.
  • Jaffetilchin Investment Partners first reported a position in ADMA Biologics in Q4 2020 and held it in 5 quarters.
  • Jaffetilchin Investment Partners's ADMA Biologics position peaked at $28K in Q4 2020.
  • 321 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.